Skip to main content
. 2021 May 8;3(4):100303. doi: 10.1016/j.jhepr.2021.100303

Table 3.

Baseline characteristics of patients in intensive care unit.

Variable Severe COVID-19 (n = 11) Severe COVID-19 + cirrhosis (n = 12) Sepsis + cirrhosis(n = 24) p value (all groups)
Age (years) 54 (34-65) 52.5 (35-72) 44 (34-78)
Male, n (%) 10 (90.9) 10 (83.3) 21 (87.5)
Female, n (%) 1 (9.09) 2 (16.6) 3 (12.5)
Neutrophil to lymphocyte ratio 8.15 (2.5-39.3) 7.8 (4.4-22.23) 13.5 (1.41-39) n.s.
Platelet count (x109/L) 210 (57-449) 59 (36-122) 114 (14-339) 0.0002
Bilirubin (mg/dl) 0.77 (0.33-3.74) 10.65 (1.07-29.8) 9.35 (1.30-32) <0.0001
AST (U/L) 54 (27-210) 49.5 (23-273) 79 (40-553) n.s.
ALT (U/L) 54.2 (18-89) 40 (21-101) 45 (16-208) n.s.
Albumin (g/dl) 3.29 (0.37) 2.8 (0.56) 2.65 (0.6) 0.001
Serum sodium (mEq/L) 131.5 (4.03) 130.5 (7.07) 128.1 (8.7) n.s.
INR 1.05 (0.96-1.74) 1.8 (0.8) 2.3 (0.7) <0.0001
Creatinine (mg/dl) 0.9 (0.53-1.65) 1.3 (0.2-3.4) 2.85 (0.5-10.22) 0.003
D-dimers (pg/ml) 2,498.3 (1,039.02) 2,916 (660.6) 3,098.6 (682.4) n.s.
Ferritin (ng/ml) 230 (133-1,540) 884.5 (276-1,670) 651.4 (103-2,220) 0.02
LDH (U/L) 533.3 (260.8) 605.1 (276.5) 561.2 (206.6) n.s.
PCT (ng/ml) 2.0 (0.9) 2.1 (1.5) 4.2 (3.1) n.s.
Mechanical ventilation, n (%) 4 (36.3) 8 (66.6) 17 (70.3) -
Etiology of liver diseases, n (%)
 Alcohol 0 (0) 6 (50) 10 (41.6) -
 HBV 0 (0) 2 (16.6) 4 (16.6) -
 HCV 0 (0) 0 (0) 3 (12.5) -
 NASH 0 (0) 3 (25) 6 (25) -
 Other 0 (0) 1 (8.3) 1 (4.1) -
Ascites, n (%) 0 (0) 9 (75) 23 (95.8) -
Hepatic encephalopathy, n (%) 0 (0) 8 (66.6) 16 (66.6) -
ARDS, n (%) 9 (81.8) 8 (66.6) 15 (62.5)
Liver disease severity n (%)
 Child-Pugh A 0 (0) 1 (8.3) 0 (0)
 Child-Pugh B 0 (0) 1 (8.3) 4 (16.6)
 Child-Pugh C 0 (0) 10 (83.3) 20 (83.3)
 MELD score - 23.3 (9.5) 31.2 (8.8) 0.01
 SOFA (day 3-5) 11.08 (2.6) 11.83 (1.8) n.s.
 CLIF-OF (day 3-5) 11.9 (2.6) 12.5 (2.3) n.s.
Organ failures, n (%)
 Liver 6 (50) 14 (58.3) n.s.
 Renal 7 (58.3) 18 (75) n.s.
 Respiratory 10 (83.3) 19 (79.2) n.s.
 Brain 6 (50) 11 (45.8) n.s.
 Circulation 6 (50) 18 (75) n.s.
 Coagulation 7 (58.3) 13 (54.2) n.s.
Infections, n (%)
 Pneumonia 12 (100) 18 (75)
 SBP 0 3 (12.5)
 Blood sepsis 0 3 (12.5)
Comorbidities n (%)
 Hypertension 6 (54.5) 5 (41.6) 10 (41.6)
 Diabetes mellitus 7 (63.6) 7 (58.3) 11 (45.8)
 Coronary artery disease 3 (27.7) 2 (16.6) 4 (16.6)
 Obesity 2 (18.1) 2 (16.6) 5 (20.8)
 Liver disease 0 (0) 12 (100) 24 (100) -
Charlson comorbidity index 2 (0-5) 4 (1-7) 4 (3-6) 0.0004

For continuous variables, values are given as mean (SD) or median (min-max) and p values have been calculated by One-way Annova or Kruskal-Wallis test. Categorical variables are given as n (%). ALT, alanine aminotransferase; ARDS, acute respiratory distress syndrome; AST, aspartate aminotransferase; CLIF-OF, chronic liver failure-organ failure; ICU, intensive care unit; INR, international normalized ratio; LDH, lactate dehydrogenase; MELD, model for end-stage liver disease; NASH, non-alcoholic steatohepatitis; PCT, procalcitonin; SBP, spontaneous bacterial peritonitis; SOFA, sequential organ failure assessment.